Cognizant to buy Astreya for about $600 million - Reuters

Reuters | April 29, 2026, 4:34 a.m. | Original
Cognizant to buy Astreya for about $600 million Reuters
AstraZeneca beats profit estimates, backs 2026 outlook on strong cancer drug sales - Reuters Taiwan tops Beijing's agenda for Trump-Xi summit - Reuters